The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Liposome and immune system interplay: Challenges and potentials
Abstract
Liposome as a revolutionizing carrier, has exhibited favorable aspects in drug delivery. However, there are numerous challenges affecting its effectiveness. Hypersensitivity, accelerated blood clearance, opsonization, uptake by reticulo-endothelial system, and also immune suppression are known as the dominant manifestations of immune-related effects. They may cause failure to achieve the proof of regulatory approvals. In this review, liposome challenges in biologic environment have been discussed. Moreover, opsonization and liposome interactions with innate and acquired immune system have been investigated. Immune system elements including the corresponding receptors and cells were reviewed in this regard. By exploring immune related interactions of the liposome, it could be possible for the formulators to be aware of the immune related interactions of the administered liposomal formulation. On the other hand, immune targeted liposomes for immunotherapy and vaccination purposes could also be developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304
Danaei, M., Dehghankhold, M., Ataei, S., Hasanzadeh Davarani, F., Javanmard, R., Dokhani, A., Khorasani, S., & Mozafari, M. R. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10020057 · Cited by 4,832
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Mellman, I., & Steinman, R. M. (2001) · Cell · doi:10.1016/s0092-8674(01)00449-4 · Cited by 2,237
Progress and challenges towards targeted delivery of cancer therapeutics
Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
The roles of TLRs, RLRs and NLRs in pathogen recognition
Kawai, T., & Akira, S. (2009) · International Immunology · doi:10.1093/intimm/dxp017 · Cited by 1,670
Moghimi, S. M., & Szebeni, J. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00033-x · Cited by 1,227
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Scavenger receptors in homeostasis and immunity
Canton, J., Neculai, D., & Grinstein, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3515 · Cited by 838
Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces
Vroman, L., Adams, A., Fischer, G., & Munoz, P. (1980) · Blood · doi:10.1182/blood.v55.1.156.156 · Cited by 781
The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage
Abu Lila, A. S., Kiwada, H., & Ishida, T. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.07.026 · Cited by 721
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Zhang, P., Sun, F., Liu, S., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.040 · Cited by 688
Protein corona: a new approach for nanomedicine design
Nguyen, V. H., & Lee, B.-J. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129300 · Cited by 638
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
Szebeni, J. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.023 · Cited by 611
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Fate and behavior of liposomes in vivo: a review of controlling factors.
Senior, J. H. (1987) · PubMed · Cited by 591
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
CD36, a scavenger receptor implicated in atherosclerosis
Park, Y. M. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.38 · Cited by 517
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes
Ishida, T., & Kiwada, H. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.005 · Cited by 490
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Application of Various Types of Liposomes in Drug Delivery Systems
Alavi, M., Karimi, N., & Safaei, M. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.002 · Cited by 466
Biomimetic proteolipid vesicles for targeting inflamed tissues
Molinaro, R., Corbo, C., Martinez, J. O., Taraballi, F., Evangelopoulos, M., Minardi, S., Yazdi, I. K., Zhao, P., De Rosa, E., Sherman, M. B., et al. (2016) · Nature Materials · doi:10.1038/nmat4644 · Cited by 451
Szebeni, J., Muggia, F., Gabizon, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 423
Semple, S. C., Chonn, A., & Cullis, P. R. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00128-2 · Cited by 402
Lyass, O., Uziely, B., Ben-Yosef, R., Tzemach, D., Heshing, N. I., Lotem, M., Brufman, G., & Gabizon, A. (2000) · Cancer · doi:10.1002/1097-0142(20000901)89:5<1037::aid-cncr13>3.0.co;2-z · Cited by 385
Palma, A. S., Feizi, T., Zhang, Y., Stoll, M. S., Lawson, A. M., Díaz-Rodríguez, E., Campanero-Rhodes, M. A., Costa, J., Gordon, S., Brown, G. D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511461200 · Cited by 374
Chonn, A., Cullis, P. R., & Devine, D. V. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4234 · Cited by 367
Ishida, T., Harada, M., Wang, X. Y., Ichihara, M., Irimura, K., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.003 · Cited by 365
Karmali, P. P., & Simberg, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.554818 · Cited by 361
Immediate‐type hypersensitivity to polyethylene glycols: a review
Wenande, E., & Garvey, L. H. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12760 · Cited by 354
Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 345
The Immunogenicity of Polyethylene Glycol: Facts and Fiction
Schellekens, H., Hennink, W. E., & Brinks, V. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1067-7 · Cited by 340
Ishida, T., Harashima, H., & Kiwada, H. (2002) · Bioscience Reports · doi:10.1023/a:1020134521778 · Cited by 330
Accelerated clearance of PEGylated liposomes in rats after repeated injections
Ishida, T., Maeda, R., Ichihara, M., Irimura, K., & Kiwada, H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00462-5 · Cited by 327
C-type lectins and phagocytosis
Kerrigan, A. M., & Brown, G. D. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.003 · Cited by 324
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion
Du, H., Chandaroy, P., & Hui, S. W. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00027-8 · Cited by 319
Lakshminarayanan, V., Thompson, P., Wolfert, M. A., Buskas, T., Bradley, J. M., Pathangey, L. B., Madsen, C. S., Cohen, P. A., Gendler, S. J., & Boons, G.-J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115166109 · Cited by 301
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
The Immune Revolution: A Case for Priming, Not Checkpoint
Vonderheide, R. H. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.008 · Cited by 293
Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.017 · Cited by 287
Hunt, J., & Krilis, S. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.653 · Cited by 269
Hershfield, M. S., Ganson, N. J., Kelly, S. J., Scarlett, E. L., Jaggers, D. A., & Sundy, J. S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4500 · Cited by 266
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome)
Lorusso, D., Di Stefano, A., Carone, V., Fagotti, A., Pisconti, S., & Scambia, G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdl477 · Cited by 265
Cationic liposomes as vaccine adjuvants
Christensen, D., Korsholm, K. S., Andersen, P., & Agger, E. M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.17 · Cited by 259
Targeting Dendritic Cells with Antigen-Containing Liposomes
van Broekhoven, C. L., Parish, C. R., Demangel, C., Britton, W. J., & Altin, J. G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0138 · Cited by 256
Liposome—complement interactions in rat serum: implications for liposome survival studies
Devine, D. V., Wong, K., Serrano, K., Chonn, A., & Cullis, P. R. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90231-3 · Cited by 248
van Dissel, J. T., Joosten, S. A., Hoff, S. T., Soonawala, D., Prins, C., Hokey, D. A., O’Dee, D. M., Graves, A., Thierry-Carstensen, B., Andreasen, L. V., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.036 · Cited by 243
β2-glycoprotein-I (apolipoprotein H) interactions with phospholipid vesicles
Wurm, H. (1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90168-x · Cited by 234
Nishikawa, K., Arai, H., & Inoue, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34110-9 · Cited by 232
Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
Perche, F., & Torchilin, V. P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/705265 · Cited by 230
Richter, A. W., & Åkerblom, E. (1984) · International Archives of Allergy and Immunology · doi:10.1159/000233512 · Cited by 229
Interactions of liposomes with the reticuloendothelial system
Hsu, M. J., & Juliano, R. L. (1982) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(82)90120-3 · Cited by 214
Tandrup Schmidt, S., Foged, C., Smith Korsholm, K., Rades, T., & Christensen, D. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8010007 · Cited by 213
Szebeni, J., Baranyi, L., Savay, S., Milosevits, J., Bunger, R., Laverman, P., Metselaar, J. M., Storm, G., Chanan-Khan, A., Liebes, L., et al. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004790 · Cited by 212
Kierstead, P. H., Okochi, H., Venditto, V. J., Chuong, T. C., Kivimae, S., Fréchet, J. M. J., & Szoka, F. C. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.023 · Cited by 210
Mima, Y., Hashimoto, Y., Shimizu, T., Kiwada, H., & Ishida, T. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00144 · Cited by 209
Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition
Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., & Frokjaer, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.11.008 · Cited by 206
Targeting tumor antigens to dendritic cells using particulate carriers
Joshi, M. D., Unger, W. J., Storm, G., van Kooyk, Y., & Mastrobattista, E. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.05.010 · Cited by 196
Daleke, D. L., Hong, K., & Papahadjopoulos, D. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90365-u · Cited by 193
Onivyde for the therapy of multiple solid tumors
Zhang, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s105587 · Cited by 187
Yan, X., Scherphof, G. L., & Kamps, J. A. A. M. (2005) · Journal of Liposome Research · doi:10.1081/lpr-200064971 · Cited by 187
Innovative strategies for co-delivering antigens and CpG oligonucleotides
Krishnamachari, Y., & Salem, A. K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.12.013 · Cited by 175
Recent progress concerning CpG DNA and its use as a vaccine adjuvant
Shirota, H., & Klinman, D. M. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.863715 · Cited by 172
Liposomal vaccine delivery systems
Henriksen‐Lacey, M., Korsholm, K. S., Andersen, P. L., Perrie, Y., & Christensen, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.558081 · Cited by 168
Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs
Gunaseelan, S., Gunaseelan, K., Deshmukh, M., Zhang, X., & Sinko, P. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.021 · Cited by 164
Moghimi, S. M., & Hunter, A. C. (2001) · Pharmaceutical Research · doi:10.1023/a:1011054123304 · Cited by 161
Bellinger-Kawahara, C., & Horwitz, M. A. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.172.4.1201 · Cited by 158
Unveiling the in Vivo Protein Corona of Circulating Leukocyte-like Carriers
Corbo, C., Molinaro, R., Taraballi, F., Toledano Furman, N. E., Hartman, K. A., Sherman, M. B., De Rosa, E., Kirui, D. K., Salvatore, F., & Tasciotti, E. (2017) · ACS Nano · doi:10.1021/acsnano.7b00376 · Cited by 155
Nanoparticle and Protein Corona
Rahman, M., Laurent, S., Tawil, N., Yahia, L., & Mahmoudi, M. (2013) · Springer series in biophysics · doi:10.1007/978-3-642-37555-2_2 · Cited by 155
Daemen, T., Hofstede, G., ten Kate, M. T., Bakker‐Woudenberg, I. A. J. M., & Scherphof, G. L. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610520 · Cited by 153
Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y. M., Kubo, K., Nakagawa, S., Nakanishi, M., Tanaka, K., & Mayumi, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00097-8 · Cited by 149
Kao, Y. J., & Juliano, R. L. (1981) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(81)90259-2 · Cited by 146
Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions
Szebeni, J., & Moghimi, S. M. (2009) · Journal of Liposome Research · doi:10.1080/08982100902792855 · Cited by 145
Nakamura, K., Yamashita, K., Itoh, Y., Yoshino, K., Nozawa, S., & Kasukawa, H. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.06.019 · Cited by 142
Juliano, R. L. (1988) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(88)90004-x · Cited by 142
Saadati, R., Dadashzadeh, S., Abbasian, Z., & Soleimanjahi, H. (2012) · Pharmaceutical Research · doi:10.1007/s11095-012-0934-y · Cited by 142
Altering the immune response with lipid-based nanoparticles
Landesman‐Milo, D., & Peer, D. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.12.034 · Cited by 142
Peroxidation of liposomal lipids
Schnitzer, E., Pinchuk, I., & Lichtenberg, D. A. (2007) · European Biophysics Journal · doi:10.1007/s00249-007-0146-2 · Cited by 141
Sadzuka, Y., Nakade, A., Hirama, R., Miyagishima, A., Nozawa, Y., Hirota, S., & Sonobe, T. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00075-3 · Cited by 139
Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy
Sun, X., Yan, X., Jacobson, O., Sun, W., Wang, Z., Tong, X., Xia, Y., Ling, D., & Chen, X. S. (2016) · Theranostics · doi:10.7150/thno.18078 · Cited by 136
Martínez‐Pomares, L., Mahoney, J. A., Káposzta, R., Linehan, S. A., Stahl, P. D., & Gordon, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.36.23376 · Cited by 132
Inhibition of Liposome-Induced Complement Activation by Incorporated Poly(Ethylene Glycol)-Lipids
Bradley, A. J., Devine, D. V., Ansell, S. M., Janzen, J., & Brooks, D. E. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0798 · Cited by 132
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Chen, W., Yan, W., & Huang, L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0390-4 · Cited by 127
Design and Development of Biomimetic Nanovesicles Using a Microfluidic Approach
Molinaro, R., Evangelopoulos, M., Hoffman, J., Corbo, C., Taraballi, F., Martinez, J. O., Hartman, K. A., Cosco, D., Costa, G., Romeo, I., et al. (2018) · Advances in Materials · doi:10.1002/adma.201702749 · Cited by 126
Qiu, H., Fan, Y., Joyee, A. G., Wang, S., Han, X., Bai, H., Jiao, L., van Rooijen, N., & Yang, X. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2092 · Cited by 125
The Interaction of Liposomes with the Complement System
Szebeni, J. (1998) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v15.i1.20 · Cited by 123
Duan, W., & Li, H. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0382-x · Cited by 122
Liposomal drug product development and quality: current US experience and perspective
Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0049-9 · Cited by 116
Overview on experimental models of interactions between nanoparticles and the immune system
Najafi-Hajivar, S., Zakeri‐Milani, P., Mohammadi, H., Niazi, M., Soleymani-Goloujeh, M., Baradaran, B., & Valizadeh, H. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.08.060 · Cited by 115
Self-citationChristensen, D., Henriksen‐Lacey, M., Kamath, A. T., Lindenstrøm, T., Korsholm, K. S., Christensen, J. P., Rochat, A., Lambert, P., Andersen, P. L., Siegrist, C., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.016 · Cited by 113
Woodworth, J. S., Cohen, S. B., Moguche, A. O., Plumlee, C. R., Agger, E. M., Urdahl, K. B., & Andersen, P. L. (2016) · Mucosal Immunology · doi:10.1038/mi.2016.70 · Cited by 113
Alving, C. R. (1992) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(92)90004-t · Cited by 112
Szebeni, J., & Storm, G. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.177 · Cited by 111
Anti-inflammatory Microglia/Macrophages As a Potential Therapeutic Target in Brain Metastasis
Andreou, K. E., Soto, M. S., Allen, P. D., Economopoulos, V., de Bernardi, A., Larkin, J. R., & Sibson, N. R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00251 · Cited by 109
Bai, L., Deng, S., Reboulet, R. A., Mathew, R. S., Teyton, L., Savage, P. B., & Bendelac, A. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303218110 · Cited by 108
Liposomal adjuvants for human vaccines
Alving, C. R., Beck, Z., Matyas, G. R., & Rao, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1151871 · Cited by 108
Yuba, E., Yamaguchi, A., Yoshizaki, Y., Harada, A., & Kono, K. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.021 · Cited by 106
Receptor versus non-receptor mediated clearance of liposomes
Scherphof, G. L., & Kamps, J. A. A. M. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00133-6 · Cited by 105
Binnemars‐Postma, K., ten Hoopen, H., Storm, G., & Prakash, J. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0233 · Cited by 103
Funato, K., Yoda, R., & Kiwada, H. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90087-3 · Cited by 102
Ojala, J. R. M., Pikkarainen, T., Tuuttila, A., Sandalova, T., & Tryggvason, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701750200 · Cited by 101
La-Beck, N. M., & Gabizón, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00416 · Cited by 99
Bal, S. M., Hortensius, S., Ding, Z., Jiskoot, W., & Bouwstra, J. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.061 · Cited by 97
Oh, H., Jo, H.-Y., Park, J. S., Kim, D., Cho, J., Kim, P., & Kim, K. (2016) · Nanomaterials · doi:10.3390/nano6080141 · Cited by 97
Tait, J. F., & Smith, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.3048 · Cited by 95
Shimizu, T., Mima, Y., Hashimoto, Y., Ukawa, M., Ando, H., Kiwada, H., & Ishida, T. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.06.005 · Cited by 91
Badiee, A., Khamesipour, A., Samiei, A., Soroush, D., Shargh, V. H., Kheiri, M. T., Barkhordari, F., Master, W. R. M., Mahboudi, F., & Jaafari, M. R. (2012) · Experimental Parasitology · doi:10.1016/j.exppara.2012.09.001 · Cited by 91
Ahl, P. L., Bhatia, S. K., Meers, P. R., Roberts, P., Stevens, R., Dause, R. B., Perkins, W. R., & Janoff, A. S. (1997) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00129-6 · Cited by 90
Liposome-targeted delivery for highly potent drugs
Bardania, H., Tarvirdipour, S., & Dorkoosh, F. A. (2017) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2017.1290647 · Cited by 89
Liposome-Mediated Triggering of Complement Cascade
Moghimi, S. M., & Hamad, I. M. (2008) · Journal of Liposome Research · doi:10.1080/08982100802309552 · Cited by 86
Wang, X., Ishida, T., Ichihara, M., & Kiwada, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.01.008 · Cited by 83
Thomann, J.-S., Heurtault, B., Weidner, S., Brayé, M., Beyrath, J., Fournel, S., Schuber, F., & Frisch, B. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.015 · Cited by 81
Engler, A. C., Ke, X., Gao, S., Chan, J. M. W., Coady, D. J., Ono, R. J., Lubbers, R., Nelson, A., Yang, Y. Y., & Hedrick, J. L. (2015) · Macromolecules · doi:10.1021/acs.macromol.5b00156 · Cited by 81
The Interaction of Liposomes with the Complement System: In Vitro and In Vivo Assays
Szebeni, J., Baranyi, L., Sávay, S., Milosevits, J., Bodó, M., Bünger, R., & Alving, C. R. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)73010-9 · Cited by 79
Liposomal Delivery of CTL Epitopes to Dendritic Cells
Chikh, G., & Schutze-Redelmeier, M.-P. M. (2002) · Bioscience Reports · doi:10.1023/a:1020151025412 · Cited by 79
Competitive adsorption of multiple proteins to nanoparticles: the Vroman effect revisited
Angioletti‐Uberti, S., Ballauff, M., & Dzubiella, J. (2018) · Molecular Physics · doi:10.1080/00268976.2018.1467056 · Cited by 79
Varypataki, E. M., Benne, N., Bouwstra, J. A., Jiskoot, W., & OSSENDORP, F. A. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0283 · Cited by 78
Fehres, C. M., Kalay, H., Bruijns, S. C. M., Musaafir, S. A. M., Ambrosini, M., van Bloois, L., van Vliet, S. J., Storm, G., García-Vallejo, J. J., & van Kooyk, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.040 · Cited by 77
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Kikuchi, H., & Ishihara, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.047 · Cited by 75
MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses
Boks, M. A., Ambrosini, M., Bruijns, S. C. M., Kalay, H., van Bloois, L., Storm, G., García-Vallejo, J. J., & van Kooyk, Y. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.06.033 · Cited by 72
Thuren, T. Y., Weisgraber, K. H., Sisson, P., & Waite, M. B. (1992) · Biochemistry · doi:10.1021/bi00123a018 · Cited by 72
Garg, M., Asthana, A., Agashe, H. B., et al. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.5.0005 · Cited by 72
Faham, A., & Altin, J. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000027 · Cited by 71
Adjuvant effect of cationic liposomes and CpG depends on administration route
Slütter, B., Bal, S. M., Ding, Z., Jiskoot, W., & Bouwstra, J. A. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.007 · Cited by 70
Immune response of a liposomal model membrane.
Haxby, J. A., Kinsky, C. B., & Kinsky, S. C. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.1.300 · Cited by 68
Selective liposome targeting of folate receptor positive immune cells in inflammatory diseases
Poh, S., Chelvam, V., Ayala-López, W., Putt, K. S., & Low, P. S. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.01.009 · Cited by 67
Sultana, F., Neog, M. K., & Rasool, M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.04.046 · Cited by 65
Karlsen, T. A., & Brinchmann, J. E. (2013) · Molecular Therapy · doi:10.1038/mt.2013.55 · Cited by 64
Xu, H., Ye, F., Hu, M., Yin, P., Zhang, W., Li, Y., Xiu, Y., & Deng, Y. (2014) · Drug Delivery · doi:10.3109/10717544.2014.885998 · Cited by 64
Coombes, J. L., Han, S., van Rooijen, N., Raulet, D. H., & Robey, E. A. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.06.001 · Cited by 64
Im, H., England, C. G., Feng, L., Graves, S. A., Hernandez, R. T., Nickles, R. J., Liu, Z., Lee, D. S., Cho, S. Y., & Cai, W. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b05840 · Cited by 63
Yamaguchi, Y., Seta, N., Kaburaki, J., Kobayashi, K., Matsuura, E., & Kuwana, M. (2007) · Blood · doi:10.1182/blood-2007-07-100008 · Cited by 62
Antibody binding and complement fixation by a liposomal model membrane
Alving, C. R., Kinsky, S. C., Haxby, J. A., & Kinsky, C. B. (1969) · Biochemistry · doi:10.1021/bi00832a038 · Cited by 61
Ganglioside inserted into PEGylated liposome attenuates anti-PEG immunity
Mima, Y., Lila, A. S. A., Shimizu, T., Ukawa, M., Ando, H., Kurata, Y., & Ishida, T. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.040 · Cited by 61
The mannose receptor is expressed by subsets of APC in non-lymphoid organs
Linehan, S. A. (2005) · BMC Immunology · doi:10.1186/1471-2172-6-4 · Cited by 58
Karmakar, P. S., Lee, K., Sarkar, S., Wall, K. A., & Sucheck, S. J. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00528 · Cited by 55
Román, R. G., Jensen, K. J., Jensen, S. S., Leo‐Hansen, C., Jespersen, S., Te, D., Rodrigues, C. M., Janitzek, C. M., Vinner, L., Katzenstein, T. L., et al. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0076 · Cited by 54
Badiee, A., Davies, N. M., McDonald, K. J., Radford, K. J., Michiue, H., Hart, D. N. J., & Kato, M. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.04.029 · Cited by 52
Zhao, Y., Jiang, C., He, J., Guo, Q., Lu, J., Yang, Y., Zhang, W., & Liu, J. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00600 · Cited by 52
Borén, J., Lõokene, A., Makoveichuk, E., Xiang, S., Gustafsson, M. V., Liu, H., Talmud, P. J., & Olivecrona, G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011090200 · Cited by 51
Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles
Klapper, Y., Hamad, O. A., Teramura, Y., Leneweit, G., Nienhaus, G. U., Ricklin, D., Lambris, J. D., Ekdahl, K. N., & Nilsson, B. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.085 · Cited by 51
Vono, M., Eberhardt, C. S., Mohr, E., Auderset, F., Christensen, D., Schmolke, M., Coler, R. N., Meinke, A. L., Andersen, P. L., Lambert, P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00381 · Cited by 51
Hattori, Y., Yamashita, J., Sakaida, C., Kawano, K., & Yonemochi, E. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.954128 · Cited by 49
The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster
Clark, A. G., Nickerson, D. A., Weiss, K. M., Salomaa, V. V., Boerwinkle, E., Fullerton, S. M., Buchanan, A. V., Sonpar, V. A., Steng�rd, J. H., Smith, J. D., et al. (2004) · Human Genetics · doi:10.1007/s00439-004-1106-x · Cited by 48
Huber, A., Kallerup, R. S., Korsholm, K. S., Franzyk, H., Lepenies, B., Christensen, D., Foged, C., & Lang, R. (2016) · Innate Immunity · doi:10.1177/1753425916651132 · Cited by 47
Antigen presenting cell-selective drug delivery by glycan-decorated nanocarriers
Frenz, T., Grabski, E., Durán, V., Hozsa, C., Stępczyńska, A., Furch, M., Gieseler, R. K. H., & Kalinke, U. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.02.008 · Cited by 44
TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines
Johnston, D., Zaidi, B., & Bystryn, J. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0262-3 · Cited by 43
Betageri, G. V., BLACK, C. D. V., Szebeni, J., Wahl, L. M., & Weinstein, J. N. (1993) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1993.tb03678.x · Cited by 42
Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use
Aversa, F., Busca, A., Candoni, A., Cesaro, S., Girmenia, C., Luppi, M., Nosari, A., Pagano, L., Romani, L. R., Rossi, G., et al. (2017) · Journal of Chemotherapy · doi:10.1080/1120009x.2017.1306183 · Cited by 42
Lawlor, K. E., Wong, P. K. K., Campbell, I. K., van Rooijen, N., & Wicks, I. P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21495 · Cited by 41
Peptide Anchor for Folate-Targeted Liposomal Delivery
Nogueira, E., Mangialavori, I. C., Loureiro, A., Azóia, N. G., Sárria, M. P., Nogueira, P., Freitas, J., Härmark, J., Shimanovich, U., Rollett, A., et al. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b00823 · Cited by 41
Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies
Brown, B. S., Patanam, T., Mobli, K., Celia, C., Zage, P. E., Bean, A. J., & Tasciotti, E. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28875 · Cited by 39
Takagi, H., Numazaki, M., Kajiwara, T., Abe, Y., Ishii, M., Kato, C., & Kojima, N. (2008) · Glycobiology · doi:10.1093/glycob/cwn128 · Cited by 39
Interaction of immunoglobulin-coupled liposomes with rat liver macrophages in vitro
DERKSEN, J. T. P., Morselt, H. W. M., Kalicharan, D., Hulstaert, C. E., & Scherphof, G. L. (1987) · Experimental Cell Research · doi:10.1016/0014-4827(87)90420-4 · Cited by 37
Abhyankar, M. M., Orr, M. T., Lin, S. X., Suraju, M. O., Simpson, A., Blust, M., Pham, T., Guderian, J. A., Tomai, M. A., Elvecrog, J., et al. (2018) · npj Vaccines · doi:10.1038/s41541-018-0060-x · Cited by 37
Matsuo, H., Funato, K., Harashima, H., & Kiwada, H. (1994) · Journal of drug targeting · doi:10.3109/10611869409015902 · Cited by 36
Boks, M. A., Bruijns, S. C. M., Ambrosini, M., Kalay, H., van Bloois, L., Storm, G., de Gruijl, T. D., & van Kooyk, Y. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.226 · Cited by 35
Tuftsin-Bearing Liposomes as Antibiotic Carriers in Treatment of Macrophage Infections
Gupta, C. M., & Haq, W. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)91016-1 · Cited by 35
Venkatakrishnan, K., Liu, Y., Noe, D. A., Mertz, J., Bargfrede, M., Marbury, T. C., Farbakhsh, K., Oliva, C., & Milton, A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12260 · Cited by 35
Andrews, C. D., Huh, M.-S., Patton, K., Higgins, D., Nest, G. V., Ott, G. S., & Lee, K. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2003835 · Cited by 35
Aramaki, Y., Akiyama, K., Hara, T., & Tsuchiya, S. (1995) · European Journal of Pharmaceutical Sciences · doi:10.1016/0928-0987(94)00075-b · Cited by 33
Li, T., He, J., Horvath, G. L., Próchnicki, T., Latz, E., & Takeoka, S. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.10.011 · Cited by 33
Li, P., Chen, S., Jiang, Y., Jiang, J., Zhang, Z., & Sun, X. (2013) · Nanotechnology · doi:10.1088/0957-4484/24/29/295101 · Cited by 32
Nogueira, E., Freitas, J., Loureiro, A., Nogueira, P., Gomes, A. C., Preto, A., Carmo, A. M., Moreira, A., & Cavaco-Paulo, A. M. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.04.023 · Cited by 32
Ghosh, J., Guha, R., Das, S., & Roy, S. (2013) · Infection and Immunity · doi:10.1128/iai.00583-13 · Cited by 31
Immune responses of therapeutic lipid nanoparticles
Chen, W. C., May, J. P., & Li, S. (2012) · Nanotechnology Reviews · doi:10.1515/ntrev-2012-0040 · Cited by 31
Arranz, A., Reinsch, C., Papadakis, K. A., Dieckmann, A., Rauchhaus, U., Androulidaki, A., Zacharioudaki, V., Margioris, A. N., Tsatsanis, C., & Panzner, S. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.008 · Cited by 30
Kruth, H. S., Zhang, W., Skarlatos, S. I., & Chao, F. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.11.7495 · Cited by 29
Mészáros, T., Csincsi, Á. I., Uzonyi, B., Hebecker, M., Fülöp, T. G., Erdei, A., Szebeni, J., & Józsi, M. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.11.019 · Cited by 29
Åslund, A., Sulheim, E., Snipstad, S., von Haartman, E., Baghirov, H., Starr, N. J., Løvmo, M. K., Lélu, S., Scurr, D. J., Davies, C. D. L., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01085 · Cited by 29
PEGylation and anti-PEG antibodies
Lila, A. S. A., Shimizu, T., & Ishida, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101750-0.00003-9 · Cited by 27
Brissette, L., Roach, P. D., & Noël, S. P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67289-8 · Cited by 25
Sharma, R. K., Mody, N., Kushwah, V., Jain, S., & Vyas, S. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0088 · Cited by 22
Blom, R. A. M., Amacker, M., van Dijk, R. M., Moser, C., Stumbles, P. A., Blank, F., & von Garnier, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00359 · Cited by 21
Valizadeh, H., Ghanbarzadeh, S., & Zakeri‐Milani, P. (2014) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.971032 · Cited by 18
Self-citationKarlsen, K. K., Korsholm, K. S., Mortensen, R. J., Ghiasi, S. M., Andersen, P. L., Foged, C., & Christensen, D. (2014) · Nanomedicine · doi:10.2217/nnm.14.197 · Cited by 18
Daunorubicin & Cytarabine Liposome (Vyxeos™)
Crain, M. L. (2018) · Oncology Times · doi:10.1097/01.cot.0000534146.30839.ec · Cited by 17
Koide, H., Asai, T., Hatanaka, K., Shimizu, K., Yokoyama, M., Ishida, T., Kiwada, H., & Oku, N. (2009) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.129.1445 · Cited by 17
Kawauchi, Y., Kuroda, Y., & Kojima, N. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9406-1 · Cited by 15
Venkatakrishnan, K., Kramer, W. G., Synold, T. W., Goodman, D. B., Sides, E. H., & Oliva, C. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1262-1 · Cited by 15
Khan, M. A., Aljarbou, A. N., Khan, M. A., & Owais, M. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00992.x · Cited by 15
Monocyte targeting and activation by cationic liposomes formulated with a TLR7 agonist
Johansen, P. T., Zucker, D., Parhamifar, L., Pourhassan, H., Madsen, D. V., Henriksen, J. R., Gad, M., Barberis, A., Maj, R., Andresen, T. L., et al. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1009444 · Cited by 15
Zhang, T., Zhou, S., Kang, L., Luo, X., Liu, Y., Song, Y., Liu, X., & Deng, Y. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.06.005 · Cited by 15
Lopes, T. C. M., Silva, D. F., Costa, W. C., Frézard, F., Barichello, J. M., Silva-Barcellos, N. M., de Lima, W. G., & Rezende, S. A. (2018) · Pathology Research International · doi:10.1155/2018/9076723 · Cited by 12
High-throughput methods for screening liposome–macrophage cell interaction
Kelly, C., Lawlor, C., Burke, C., Barlow, J. W., Ramsey, J. M., Jefferies, C. A., & Cryan, S. (2014) · Journal of Liposome Research · doi:10.3109/08982104.2014.987785 · Cited by 11
Kawauchi, Y., Takagi, H., Hanafusa, K., Kono, M., Yamatani, M., & Kojima, N. (2014) · Cytokine · doi:10.1016/j.cyto.2014.08.002 · Cited by 11
Attenuating the immunogenicity of PEGylated liposomes by gangliosides
Park, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.002 · Cited by 9
Kawauchi, Y., Igarashi, M., & Kojima, N. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.01.004 · Cited by 8
Mannose receptor (CD206)-mediated imaging in sentinel lymph node localization
Azad, A. K., & Schlesinger, L. S. (2015) · Clinical and Translational Imaging · doi:10.1007/s40336-015-0117-z · Cited by 5
Cited by
Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery
Shi, L., Zhang, J., Zhao, M., Tang, S., Cheng, X., Zhang, W., Li, W., Liu, X., Peng, H., & Wang, Q. (2021) · Nanoscale · doi:10.1039/d1nr02065j · Cited by 808
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
“364 Their inherent ability to transport both hydrophobic and hydrophilic agents, 347 combined with their ease of synthesis, extensive surface area, and adaptability for targeted modi fi cations, positions them as a pivotal vehicle for drug delivery.”
BackgroundResearch progress in membrane fusion-based hybrid exosomes for drug delivery systems
Liu, A., Yang, G., Liu, Y., & Liu, T. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.939441 · Cited by 88
Fan, X., Jiang, K., Geng, F., Lu, W., & Wei, G. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114864 · Cited by 33
Metadata
- Authors
- Zahednezhad, F., Saadat, M., Valizadeh, H., Zakeri-Milani, P., & Baradaran, B.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 305
- Pages
- 194-209
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2946446720
- Cited by
- 267
- References
- 194
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.